Scientists test first-ever therapy to make human cells young again
Human trials have officially commenced for the first-ever gene therapy designed to rejuvenate human cells and reverse aging.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Scientists have launched the first human trials for a gene therapy focused on cell rejuvenation. The initiative aims to test whether cellular reprogramming can make human cells young again.
Coverage from Yahoo, Times Now, and inkorr emphasizes that this represents a new milestone in the field. Oncodaily specifically attributes this development to Ron DePinho.
Future developments depend on the outcomes of these trials to determine if science can effectively help humans reverse aging, as questioned by the Dallas Express.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 3h ago.
Quick answers
What is being tested in these trials?
A gene therapy aimed at cell rejuvenation and cellular reprogramming to make human cells young again.
Who is associated with this milestone?
According to Oncodaily, Ron DePinho is linked to this milestone in cellular reprogramming.
Has the therapy been proven successful?
Coverage indicates that human trials have begun, but does not specify the results of the testing.
Coverage (5)
- Human Trials Begin for Gene Therapy Aimed at Cell Rejuvenation inkorr.com · 1d ago
- Can Science Help Humans Reverse Aging? Dallas Express · 1d ago
- The World’s First ‘Reverse-Ageing’ Human Trial Has Begun Times Now · 1d ago
- Ron DePinho: A New Milestone in Cellular Reprogramming Oncodaily · 1d ago
- Scientists test first-ever therapy to make human cells young again Yahoo · 1d ago
Topics
Related trends
Suit Says Toyota Charity Took Plans for EV to Aid Farmers
Toyota faces legal action over allegations of copying an electric vehicle design it previously supported.
‘It would do very well:’ DeSantis agrees Buc-ee’s should open new spot at this Florida junction
Social Security change for 3.6 million beneficiaries starts this month
3.6 million Social Security beneficiaries will see a change in how they receive their payments this summer.
Soaring Profits in EM Build the Case for a Raging Bull Market
Emerging-market stocks surge to near-record highs, sparking bull market discussions
Ken Griffin fires back at Mamdani, says business leaders must 'fight for their city'
Billionaire Ken Griffin calls on New York City business leaders to push back against a local politician's anti-business agenda.
Oil prices face sudden $150 spike after vital route shuts
Oil prices surge after a critical maritime route closes, disrupting global trade.